SANUWAVE Health Inc. Fundamental Analysis (NASDAQ: SNWV)
SANUWAVE Health Inc. Fundamental Analysis (NASDAQ: SNWV)
SANUWAVE Health Inc. (NASDAQ: SNWV) shows moderate financial fundamentals with a PE ratio of 3.69, profit margin of 32.60%, and ROE of 17.28%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 49.7/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze SNWV's fundamental strength across five key dimensions:
Efficiency Score
ExcellentSNWV demonstrates superior asset utilization.
Valuation Score
ExcellentSNWV trades at attractive valuation levels.
Growth Score
ModerateSNWV shows steady but slowing expansion.
Financial Health Score
ModerateSNWV shows balanced financial health with some risks.
Profitability Score
ExcellentSNWV achieves industry-leading margins.
Key Financial Metrics
Is SNWV Expensive or Cheap?
P/E Ratio
SNWV trades at 3.69 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, SNWV's PEG of 0.01 indicates potential undervaluation.
Price to Book
The market values SANUWAVE Health Inc. at 19.01 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 2.86 times EBITDA. This is generally considered low.
How Well Does SNWV Make Money?
Net Profit Margin
For every $100 in sales, SANUWAVE Health Inc. keeps $32.60 as profit after all expenses.
Operating Margin
Core operations generate 1.54 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $17.28 in profit for every $100 of shareholder equity.
ROA
SANUWAVE Health Inc. generates $39.10 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
SANUWAVE Health Inc. produces operating cash flow of $5.62M, showing steady but balanced cash generation.
Free Cash Flow
SANUWAVE Health Inc. generates strong free cash flow of $6.49M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.76 in free cash annually.
FCF Yield
SNWV converts 12.87% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
3.69
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.008
vs 25 benchmark
P/B Ratio
Price to book value ratio
19.01
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.21
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
2.56
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.28
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
17.28
vs 25 benchmark
ROA
Return on assets percentage
0.39
vs 25 benchmark
ROCE
Return on capital employed
0.04
vs 25 benchmark
How SNWV Stacks Against Its Sector Peers
| Metric | SNWV Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 3.69 | 31.47 | Better (Cheaper) |
| ROE | 1728.10% | 382.00% | Excellent |
| Net Margin | 32.60% | -24736.00% (disorted) | Strong |
| Debt/Equity | 2.56 | 0.78 | Weak (High Leverage) |
| Current Ratio | 1.28 | 5.30 | Neutral |
| ROA | 39.10% | 1631.00% | Weak |
SNWV outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROE, but lagging in Debt/Equity.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews SANUWAVE Health Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation